Adaptive Management of Cervical Cancer Radiotherapy

Seminars in Radiation Oncology

Volumn 20, Issue 2, 2010, Pages 121-129

  Tanderup, Kari ^a   Georg, Dietmar ^b   Pötter, Richard ^b   Kirisits, Christian ^b   Grau, Cai ^a   Lindegaard, Jacob C ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE RADIOTHERAPY; ADVERSE OUTCOME; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; RECTUM HEMORRHAGE; REVIEW; TREATMENT PLANNING; TUMOR REGRESSION; TUMOR VOLUME; UNCERTAINTY; UTERINE CERVIX CANCER;

BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MOVEMENT; PATIENT POSITIONING; RADIOGRAPHY, INTERVENTIONAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; UTERINE CERVICAL NEOPLASMS;

EID: 77249138312     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2009.11.006     Document Type: Review

References (50)

1. Gerbaulet A., Pötter R., and Haie-Meder C. Cervix carcinoma. In: Gerbaulet A., Pötter R., Mazeron J.J., et al. (Eds). The GEC ESTRO Handbook of Brachytherapy (2002), ESTRO, Brussels, Belgium 301-364
2. Dimopoulos J.C., Lang S., Kirisits C., et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 75 (2009) 56-63
3. Pötter R., Dimopoulos J., Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 83 (2007) 148-155
4. Dimopoulos J.C., Potter R., Lang S., et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 93; (2009) 311-312
5. Mundt A.J., Lujan A.E., Rotmensch J., et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52 (2002) 1330-1337
6. Brixey C.J., Roeske J.C., Lujan A.E., et al. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 54 (2002) 1388-1396
7. Chen M.F., Tseng C.J., Tseng C.C., et al. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: Comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1438-1444
8. Mayr N.A., Taoka T., Yuh W.T., et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 52 (2002) 14-22
9. van de Bunt L., Jurgenliemk-Schulz I.M., de Kort G.A., et al. Motion and deformation of the target volumes during IMRT for cervical cancer: What margins do we need?. Radiother Oncol 88 (2008) 233-240
10. Taylor A., and Powell M.E. An assessment of interfractional uterine and cervical motion: Implications for radiotherapy target volume definition in gynaecological cancer. Radiother Oncol 88 (2008) 250-257
11. Beadle B.M., Jhingran A., Salehpour M., et al. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 73 (2009) 235-241
12. Chan P., Dinniwell R., Haider M.A., et al. Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: A cinematic-MRI point-of-interest study. Int J Radiat Oncol Biol Phys 70 (2008) 1507-1515
13. Georg P., Georg D., Hillbrand M., et al. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies. Radiother Oncol 80 (2006) 19-26
14. Cozzi L., Dinshaw K.A., Shrivastava S.K., et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 89 (2008) 180-191
15. Beriwal S., Gan G.N., Heron D.E., et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 68 (2007) 166-171
16. Raaymakers B.W., Lagendijk J.J., Overweg J., et al. Integrating a 1.5 T MRI scanner with a 6 MV accelerator: Proof of concept. Phys Med Biol 54 (2009) N229-N237
17. Kerkhof E.M., Raaymakers B.W., van der Heide U.A., et al. Online MRI guidance for healthy tissue sparing in patients with cervical cancer: An IMRT planning study. Radiother Oncol 88 (2008) 241-249
18. Jhingran A. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin Radiat Oncol 16 (2006) 144-151
19. Wolfson A.H. Magnetic resonance imaging and positron-emission tomography imaging in the 21st century as tools for the evaluation and management of patients with invasive cervical carcinoma. Semin Radiat Oncol 16 (2006) 186-191
20. Georg D., Kirisits C., Hillbrand M., et al. Image-guided radiotherapy for cervix cancer: High-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys 71 (2008) 1272-1278
21. Assenholt M.S., Petersen J.B., Nielsen S.K., et al. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol 47 (2008) 1337-1343
22. Lindegaard J.C., Tanderup K., Nielsen S.K., et al. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 71 (2008) 756-764
23. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
24. Pötter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO Working Group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
25. Kirisits C., Pötter R., Lang S., et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 901-911
26. Kirisits C., Lang S., Dimopoulos J., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 65 (2006) 624-630
27. De Brabandere M., Mousa A.G., Nulens A., et al. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 88 (2008) 217-226
28. Chargari C., Magne N., Dumas I., et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 74 (2009) 133-139
29. Haie-Meder C, Chargari C, Rey A, et al: Preoperative MRI-based low dose-rate brachytherapy followed by surgery in the early cervix cancer patients: Experience of the Institut Gustave Roussy. Radiother Oncol (in press)
30. Kirisits C., Lang S., Dimopoulos J., et al. Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer. Radiother Oncol 81 (2006) 269-275
31. Beriwal S., Kim H., Coon D., et al. Single magnetic resonance imaging vs magnetic resonance imaging/computed tomography planning in cervical cancer brachytherapy. Clin Oncol (R Coll Radiol) 21 (2009) 483-487
32. Dimopoulos J.C., Schard G., Berger D., et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys 64 (2006) 1380-1388
33. Dimopoulos J.C., Kirisits C., Petric P., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 66 (2006) 83-90
34. Pötter R., Kirisits C., Fidarova E.F., et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 47 (2008) 1325-1336
35. Tanderup K., Hellebust T.P., Lang S., et al. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol 89 (2008) 156-163
36. De Leeuw A.A., Moerland M.A., Nomden C., et al. Applicator reconstruction and applicator shifts in 3D MR based PDR brachytherapy of cervical cancer. Radiother Oncol 93 (2009) 341-346
37. Lim K., Kelly V., Stewart J., et al. Pelvic radiotherapy for cancer of the cervix: Is what you plan actually what you deliver?. Int J Radiat Oncol Biol Phys 74 (2009) 304-312
38. Tanderup K., Christensen J.J., Granfeldt J., et al. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry. Radiother Oncol 79 (2006) 87-93
39. Viswanathan A.N., Dimopoulos J., Kirisits C., et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 68 (2007) 491-498
40. Lin L.L., Mutic S., Low D.A., et al. Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET. Int J Radiat Oncol Biol Phys 67 (2007) 91-96
41. Van Dyk S., Narayan K., Fisher R., et al. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. Int J Radiat Oncol Biol Phys 75 (2009) 64-70
42. Petric P., Dimopoulos J., Kirisits C., et al. Inter- and intraobserver variation in HR-CTV contouring: Intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol 89 (2008) 164-171
43. Kirkpatrick J.P., Meyer J.J., and Marks L.B. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 18 (2008) 240-243
44. Brenner D.J. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18 (2008) 234-239
45. Bentzen S.M. Quantitative clinical radiobiology. Acta Oncol 32 (1993) 259-275
46. Roberts S.A., Hendry J.H., Swindell R., et al. Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: A radiobiological analysis of a randomised clinical trial. Radiother Oncol 70 (2004) 63-74
47. Chemotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26 (2008) 5802-5812
48. Barraclough L.H., Swindell R., Livsey J.E., et al. External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed. Int J Radiat Oncol Biol Phys 71 (2008) 772-778
49. Koom W.S., Sohn D.K., Kim J.Y., et al. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys 68 (2007) 1446-1454
50. Georg P., Kirisits C., Goldner G., et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol 91 (2009) 173-180